Generics 27

Originals

Biosimilars

Medical devices 10

Nutraceuticals

Filters

Hypromellose manufacturers

27 products found

Filters

27 products found

hypromellose

Eye drops 0.3% - 10ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15107
In the global ophthalmic market, it is a rapidly expanding company. They manufacture in FDA and European Health Authority-certified facilities. They are governed by quality management standards like ISO 13485:2012 and Directive 93/42/EEC. Dry Eye, Ocular Hygiene, Infection, Blepharitis, Allergy, and Glaucoma are among the therapeutic classes for which they have developed, manufactured, and commercialized pharmaceutical and medical device products.

Manufacturer usually replies in 4 days

hypromellose

Eye drops 0.32% - 0.5ml N30

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15107
In the global ophthalmic market, it is a rapidly expanding company. They manufacture in FDA and European Health Authority-certified facilities. They are governed by quality management standards like ISO 13485:2012 and Directive 93/42/EEC. Dry Eye, Ocular Hygiene, Infection, Blepharitis, Allergy, and Glaucoma are among the therapeutic classes for which they have developed, manufactured, and commercialized pharmaceutical and medical device products.

Manufacturer usually replies in 4 days

hypromellose

Eye drops 3 mg/ml - 10 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Manufacturer #12923
It is the successor of one of the largest pharmaceutical manufacturers in southeast Europe. To date, it has been present over 60 years of experience in the development, production, and sale of generic drugs for human and veterinary use. It has a pharmaceutical plant with facilities for the production of the following dosage forms: capsules and tablets, liquid sterile and dry injection forms, semi-solid forms, creams, and ointments for skin and eye use. The plant has the necessary production licenses and certificates of GMP for all productions.

Manufacturer usually replies in 9 days

hypromellose

Eye drops 0.3%

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17618
It is a prominent healthcare firm that focuses on the development, manufacture, and commercialization of consumer healthcare and pharmaceutical products (including medical devices and licensed medicines) through its branded product portfolio and contract manufacturing services for retail brand owners. With its vast Eye Care & Contact Lens Care product range, it is a market leader in the ophthalmology sector, as well as in its other major business areas of Hay Fever & Allergy and Ear Care.

Manufacturer usually replies in 8 days

hypromellose

Nasal powder TBD

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #15011

Manufacturer usually replies in 7 days

hypromellose

Eye drops 0.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #17336
For more than 70 years, eye drops have been and continue to be the competency. The company's first pharmaceutical product was an eye tonic, which was followed by a series of advancements over the next few decades. Manufacturing began in the 2010s with a fully automatic production and conditioning line, after building a new facility in the 2000s and investing in any further additions. A new packing plant began operations in the 2020s, and construction on a new warehouse and laboratory facility began. It has over fifty well-known pharmaceutical customers in Germany, Europe, and other countries like Australia, China, and Canada.

Manufacturer usually replies in 16 days

hypromellose

Eye drops 3 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #20788

Manufacturer usually replies in 2 days

hypromellose + polyvinyl alcohol + naphazoline

Eye drops 15 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #15157
It began as a Mexican firm in the 1950s, to manufacture ophthalmological drugs that met the highest quality requirements to meet market demands. It is a pharmaceutical firm that specializes in ophthalmological medicines, proteolytic enzymes, oral antibiotics, and anti-vertigo treatments, among other things. They have operations in over 100 countries.

Manufacturer usually replies in 4 days

hypromellose + polyvinyl alcohol + naphazoline

Eye drops 0.50 mg + 2.20 mg + 10.00 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Colombia
GMP approvals
INVIMA
Manufacturer #15157
It began as a Mexican firm in the 1950s, to manufacture ophthalmological drugs that met the highest quality requirements to meet market demands. It is a pharmaceutical firm that specializes in ophthalmological medicines, proteolytic enzymes, oral antibiotics, and anti-vertigo treatments, among other things. They have operations in over 100 countries.

Manufacturer usually replies in 4 days

hypromellose + dextran 70

Eye drops 0.3% + 0.1%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Registered in
Jordan
Manufacturer #6980
It was established in the late 1980s. It is one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of ophthalmology, ear, nose & throat, respiratory, and dermatology. After many years of success, the company is still focused on its differentiator and is proud to be one of the leaders in the MENA region having expanded into more than 5 production lines producing 140+ registered products, and exporting to 30+ markets globally.

Manufacturer usually replies in 6 days

hypromellose

Eye drops 0.3 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340

Manufacturer usually replies in 8 days

hypromellose

Eye drops 2 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20224

Manufacturer usually replies in 9 days

hypromellose

Eye drops 0.30% w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18647

Manufacturer usually replies in 8 days

hypromellose + dextran 70

Ophthalmic solution 3 mg + 1 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days

hypromellose

Eye drops 0.3% w/v

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18331

Manufacturer usually replies in 10 days

hypromellose

Eye drops 3mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #16167

Manufacturer usually replies in 7 days

hypromellose

Eye drops 0.30 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19051

Manufacturer usually replies in 14 days

hypromellose

Eye drops 0.32 % - 0.5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #31072

hypromellose

Eye drops 0.3%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Peru
GMP approvals
WHO
Manufacturer #18721

hypromellose + dextran 70

Eye drops 0.3% + 0.1% - 15 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Peru
GMP approvals
WHO
Manufacturer #18721

Want to view all 27 products? Create your free account today!

HYPROMELLOSE

Hypromellose is popularly called artificial tears. It prevents corneal damage in patients with kerato- conjunctivitis sicca accompanying rheumatoid arthritis, xerophthalmias, or keratitis. It moistens hard contact lenses and lubricates artificial eyes during Gonioscopy procedures. Hypromellose actions provide relief of dry eye conditions immediate. These include dry eye conditions associated with the use of TVs, infrequent blinking, some therapies, pollution, and a dry atmosphere. It is used as eye drops and a component of controlled-delivery in oral medicaments. It is used in HPMC matrices and oral controlled delivery systems. It is also used in a wide range of commercial products. As a food additive, Hypromellose is used as a thickening, suspending agent emulsifier, and an animal gelatin alternative. Hypromellose has other uses such as acting as a thickening agent, binder, hydrophilic matrix material, and film former. Hypromellose is sold under the brand names Hymelose, Hyprosol, Ikleen amongst others. Yea-Sheng Yang filed for the first patent in relation to Hypromellose in 2002. Noack Robert M. later filed a patent for Oral extended-release tablets and methods of making and using the same in 2002. Since it is essential to mix ingredients, Hypromellose is involved in several formulations and patents by several companies around the world.

Dosage and administration

Hypromellose is sold as oral & ophthalmic solution in 18 mg/1mL and 25 mg/1mL strengths. The dose for adults, children, and the elderly is one or two drops topically instilled into the eye, three times a day or directed by the doctors.

The price of Hypromellose

In the USA, consumers have to pay an average retail price of USD 24.30 for a supply of 15 milliliters. The price of 0.3%/ml eye drops cost USD 0.35 for a supply of 10ml.

How does it work?

Hypromellose increases corneal wetting by the stabilization and thickening of the precorneal tear film. Its actions also prolong the tear film breakdown time, which is very short in people with dry eye conditions. Its ingredients also lubricate and protect the eye. Hypromellose’s surface-active properties stabilize the tear film and increase tear viscosity, resulting in prevention and delay in tear evaporation and delay tear drainage. In patients with dry eyes caused by mucin deficiency, its surface activity and its adsorptive capacity make hypromellose ideal for use. Hypromellose actions create an aqueous solution, a reduced surface tension, and an increased level of viscosity. Hypromellose provides ample moisture to the cornea and conjunctiva.

Finding Hypromellose Manufacturers and Suppliers

The best way to find and gain access to Hypromellose manufacturers and Hypromellose suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Hypromellose can be a time- consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Hypromellose to work with. You can fine-tune your search results using various filters too, letting you search for Hypromellose from specific countries.